Impulse control disorder
1 paper
- Human trial1
Trial sponsors
Company1 trialPhase 4150 people
Latest
1 in 12 monthsAAIC 2025 Abstract
Antioxidant N ‐acetylcysteine as an intervention for neuropsychiatric symptoms in individuals with vascular mild cognitive impairment
Randomised trial in 59 peopleAcetylcysteine